Changes big and small can benefit those of us with MASH
As leaves fall from the trees, columnist Kathryn Hudson celebrates the changes, both big and small, that have improved her health with MASH.| Liver Disease News
Shortly after I was diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), my gastroenterologist told me that, unless it was an emergency, elective surgeries were off the table. After years of hobbling on a cane and hearing orthopedists confirm how bad my knee’s osteoarthritis had become, I quietly accepted that I’d be living with chronic pain for […] The post Surgery with liver disease is risky, but I’m holding steady appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
A long-term ketogenic diet, which favors fats over carbs, may promote weight loss, but it can also cause fatty liver disease and blood sugar problems, according to new research done in mice. “One thing that’s very clear is that if you have a really high-fat diet, the lipids [fatty molecules] have to go somewhere, and […] The post Long-term ketogenic diet may cause fatty liver disease, per mouse study appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
AX-0810, an experimental medication Proqr Therapeutics is developing for biliary atresia and another liver disease called primary sclerosing cholangitis (PSC), is about to enter clinical testing. Proqr recently announced that regulatory authorities in the European Union have given the go-ahead to launch a Phase 1 clinical trial to test AX-0810 in healthy volunteers. According to […] The post Potential biliary atresia treatment AX-0810 to enter clinical testing appeared first on Liver Diseas...| Liver Disease News – The Web's Daily Resource for Liver Disease News
Kezar Life Sciences has hit a roadblock in plans to develop zetomipzomib, its experimental treatment for autoimmune hepatitis (AIH). The company has been unable to reach an agreement with the U.S. Food and Drug Administration (FDA) about plans for a registrational clinical trial — a trial whose data, if positive, could support future applications seeking […] The post Autoimmune hepatitis therapy hits FDA roadblock, future uncertain appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Health Canada has conditionally approved Gilead Sciences’ seladelpar — to be marketed in the country under the brand name Lyvdelzi — as a second-line therapy for adults with primary biliary cholangitis (PBC). The oral treatment is cleared for use in combination with the first-line PBC therapy ursodeoxycholic acid (UDCA) in patients who don’t adequately respond […] The post Seladelpar approved in Canada as Lyvdelzi to treat adults with PBC appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
When I was in fourth grade, I was suddenly promoted into the gifted and talented program. I didn’t realize that being a mouthy brat who challenged every teacher would land me in a class designed to “cure my boredom” — the occupational hazard of a kid who read a little faster and questioned a little […] The post Finding hope for the future of transplants in a pig liver appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Itching was the main symptom leading to the diagnosis of progressive familial intrahepatic cholestasis (PFIC) type 3 in a teenage boy in Portugal, a case study reported. The boy’s symptoms resolved within two months after starting ursodeoxycholic acid (UDCA), a first-line cholestasis treatment marketed as Actigall and Urso in the U.S. and also available in […] The post Itching was main sign of teen’s liver disease: Case report appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Life has been busy in our household. School has been in session for over a month, our oldest son is playing fall baseball, and we recently took a 10-day trip to New York for my brother’s wedding. Our boys, Jackson and Finley, had an amazing time. It was by far the longest they’d been away […] The post Monitoring our son’s nutrition can be extra challenging during travel appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
A new dataset from genomics company Helix aims to accelerate research into metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The dataset, with information from more than 17,000 people, is part of Helix’s GenoSphere platform, which combines genetic and clinical data with the goal of improving scientific understanding of disease processes and […] The post New Helix dataset aims to accelerate liver disease research appeared first on Liver Disease ...| Liver Disease News – The Web's Daily Resource for Liver Disease News
Treatment with Livmarli (maralixibat) quickly and safely reduced severe itching in a 16-year-old boy with Alagille syndrome after his transplanted liver started to malfunction, a case study reports. The therapy also reduced blood levels of bile acids, the main component of the digestive fluid bile that is transported from the liver to the intestines. High bile […] The post Livmarli eases Alagille teen’s itch following liver transplant issues appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
The Web's Daily Resource for Liver Disease News| Liver Disease News
As leaves fall from the trees, columnist Kathryn Hudson celebrates the changes, both big and small, that have improved her health with MASH.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, including stroke, gene regulation, cancer, and rare...| Liver Disease News
Roche is acquiring 89bio and its fatty liver disease therapy candidate pegozafermin, being tested for MASH in two global clinical trials.| Liver Disease News
Nesfatin-1 (NF-1), a hormone that may ease cellular stress, reduced injury to the placenta in a mouse model of ICP, a study found.| Liver Disease News
Columnist Jay Sandstrom didn't expect his son's routine surgery to involve complications. But with Alagille syndrome, anything is possible.| Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Hepatitis B treatment needs a global overhaul to meet the WHO’s goal of eliminating the virus as a public health threat by 2030, per a study.| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
Eating healthy foods is vital with liver disease, but inflation can make this challenging. Columnist Kathryn Hudson shares her budget tips.| Liver Disease News
Category archive page for Fatty liver disease.| Liver Disease News
Hepatitis treatment differs based on the type of hepatitis a person has, and include therapies to address the cause of liver inflammation.| Liver Disease News
Hepatitis C is a viral infection spread through contact with bodily fluids and causes a range of symptoms affecting the liver.| Liver Disease News
A genetic disease, Alagille syndrome can cause a wide range of symptoms, including liver problems, and affects about 1 in 30,000 newborns.| Liver Disease News
A range of treatment options, including medications and procedures, are available for managing Alagille syndrome symptoms.| Liver Disease News
Common symptoms of cholestasis, a condition affecting the flow of bile from the liver, include jaundice and itchy skin.| Liver Disease News
Cholestasis, or problems with liver bile flow, can have different causes and occur in pregnancy, with symptoms like jaundice and dark urine.| Liver Disease News
Category archive page for News.| Liver Disease News
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.| Liver Disease News
The American Liver Foundation's 2025 Liver Life Walk spotlights Domenic Frappolli of Dallas, who was born with biliary atresia.| Liver Disease News
Category archive page for Columns.| Liver Disease News
